![]() |
|
||||||||
| Degree: | PharmD |
| Institution: | University of British Columbia |
| Year: | 1998 |
| Degree: | ACPR |
| Institution: | Royal Columbia Hospital |
| Year: | 1996 |
| Degree: | BSc (Pharmacy) |
| Institution: | Memorial University of Newfoundland |
| Year: | 1995 |
| Degree: | BSc (Chemistry) |
| Institution: | Dalhousie University |
| Year: | 1992 |
| Position: | Clinical Scientist, Department of Emergency Medicine |
| Organization: | Isaak Walton Killam Health Centre |
| Period: | 2010-2011 |
| Position: | Clinical Coordinator, Department of Pharmacy |
| Organization: | Capital District Health Authority |
| Period: | 2006-2011 |
| Position: | Pharmacotherapeutic Specialist, Emergency Medicine |
| Organization: | Capital District Health Authority |
| Period: | 2006-2011 |
| Position: | Associate Professor, College of Pharmacy |
| Organization: | Dalhousie University |
| Period: | 2006-2011 |
| Position: | Associate Professor, Department of Emergency Medicine |
| Organization: | Dalhousie University |
| Period: | 2006-2011 |
| Position: | Associate Dean, Practice Innovation |
| Organization: | Faculty of Pharmaceutical Sciences, University of British Columbia |
| Period: | 2011-present |
| Position: | Associate Professor |
| Organization: | Faculty of Pharmaceutical Sciences, University of British Columbia |
| Period: | 2011-present |
Dr. Zed has maintained a high-level and innovative clinical practice in Emergency Medicine since 1998, and has established a practice in two tertiary-care academic emergency departments. Within this practice specialty he has sustained a productive research program for both clinical and practice-based research with a consistent record of extra-mural funding. He has also been actively involved in teaching undergraduate pharmacy students, pharmacy residents and Pharm.D. students as well as many other health-care professionals both within the classroom setting and at the bedside throughout his academic career at UBC and Dalhousie University. He has a number of research interests surrounding many pharmacotherapy areas in emergency medicine and pharmacy practice. His academic track record includes over 70 peer-reviewed publications and over 80 conference research abstracts. He has been the recipient of many awards for research, teaching and service which includes being a two-time recipient of the Dr. Jessie I. MacKnight Award for Excellence in Teaching at the College of Pharmacy, Dalhousie University; Preceptor of the Year Award, Doctor of Pharmacy Program, Faculty of Pharmaceutical Sciences, UBC; and he is a seven-time recipient of National Awards from the Canadian Society of Hospital Pharmacy (CSHP).
Dr. Zed has a number of areas special interest, which includes pharmacotherapeutics, pharmacy practice and critical appraisal/evidence-based medicine. Pharmacotherapy areas of expertise include acute management with a focus on emergency care with particular interest in cardiovascular disease (acute coronary syndromes, arrhythmias, advanced cardiac life support), infectious disease (community-acquired infections), sedation and analgesia (acute trauma, procedural sedation), airway pharmacology (rapid sequence intubation) and toxicology. In addition he has an interest in adverse drug events with focus on identification, resolution and prevention. Dr. Zed has a particular interest in evidence-based medicine, critical appraisal and clinical decision making.
Dr. Zed has developed areas of research interest around his clinical practice in emergency medicine and has focused on two primary areas which include pharmacotherapy best practice in emergency medicine and patient safety, particularly adverse drug events.
Research involving pharmacotherapy best practice has been focused in a number of areas but includes: (i) pharmacotherapy considerations in rapid sequence intubation with particular interest in the induction agent etomidate: (ii) procedural sedation and analgesia; (iii) acute pain management; (iv) antimicrobial use in the emergency department; and (v) cardiovascular disease.
Patient safety research has focused on better understanding the incidence, severity and preventability of adverse drug events that result in hospital admission and emergency department visits. In addition, patient, prescriber, drug and system factors have been explored to identify factors that may predispose patient to the development of an adverse drug event.
Medication-related emergency department visits in pediatrics: a prospective observational study
Intravenous cefazolin plus oral probenecid vs. oral cephalexin for the treatment of cellulitis: a randomized controlled trial
The utility of end-tidal capnography during procedural sedation and analgesia in the emergency department: a randomized controlled trial
Procedural sedation for cardioversion in the emergency department: are there differences in practice compared to sedation for more painful procedures?
Andolfatto G, Abu-Laban RB, Zed PJ, Staniforth SM, Stackhouse S, Moadebi S, Willman E. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: a randomized double-blind trial. Ann Emerg Med 2012;59 doi:10.1016/j.annemergmed.2012.01.017.
Zed PJ, Ensom MHH, Slavik RS, Wilbur K, Kanji S, Koshman S, Irvine-Meek J, Perreault M, Zelenitsky S. Evaluation of the Research Grant Program of the Foundation of the Canadian Society of Hospital Pharmacists, 1995-2008. Can J Hosp Pharm 2011;64:399-404.
Sih K, Campbell SG, Tallon J, Magee K, Zed PJ. Ketamine and emergency medicine: controversies and recent advances. Ann Pharmacother 2011;45:1525-34.
Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department. Ann Pharmacother 2011;45:881-7.
Hohl CM, Nosyk B, Kuramoto L, Zed PJ, Brubacher JR, Abu-Laban RB, Sheps SB, Sobolev B. Outcomes of emergency department patients who present with adverse drug events. Ann Emerg Med 2011;58:270-9.
« Back